Syncom Formulations (India) informs about standalone unaudited financial results

23 Dec 2017 Evaluate

Syncom Formulations (India) has informed about submission of Revised Standalone Unaudited Financial Results along with Limited Review Report thereon by Statutory Auditors for Quarter/ Half-Year ended on 30th September, 2017 in accordance with Regulation 33 of the SEBI (LODR) Regulations, 2015.

The above information is a part of company’s filings submitted to BSE.

Syncom Formulations Share Price

11.75 -0.25 (-2.08%)
09-Mar-2026 14:25 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1808.65
Dr. Reddys Lab 1285.90
Cipla 1323.90
Zydus Lifesciences 904.70
Lupin 2299.55
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×